SCHEMBL8154912

SCHEMBL8154912

NN(OC=O)C(=O)C=Cc1ccc2ccccc2c1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.50
▸ CYP1A2 P05177 2/20 0.47
▸ CYP1A1 P04798 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP1B1 Q16678 1/20 0.47
▸ PTPN1 P18031 2/20 0.47
▸ PTGS1 P23219 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ APP P05067 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ CNR2 P34972 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8154910 0.78 CYP3A4 (0.54) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL9877044 0.75 ALOX5 (0.61) PTGS1
SCHEMBL1380884 0.74 CYP3A4 (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL30209649 0.74 CYP3A4 (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL1479925 0.74 CYP3A4 (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL2744147 0.73 CYP3A4 (0.61) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL2744149 0.73 CYP3A4 (0.61) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL78427 0.72 RELA (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL6552210 0.72 RELA (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1
SCHEMBL78426 0.72 RELA (0.62) CYP3A4CYP1A2CYP1A1CYP2D6CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080770-A SUBSTITUTED 1,2,3-TRIAZOLE OR 1,2,4-TRIAZOLE COMPOUND NOVO NORDISK A/S (DK) 2000-06-27 — — US disclosed
US-6063800-A Modulators of molecules with phosphotyrosine recognition units NOVO NORDISK A/S (DK) 2000-05-16 — — US disclosed
US-5972978-A FOR USE IN TREATMENT OF HUMAN AND ANIMAL DISORDERS, USE FOR PURIFICATION OF PROTEINS OR GLYCOPROTEINS, USE IN DIAGNOSIS NOVO NORDISK A/S (DK) 1999-10-26 — — US disclosed
US-5958957-A PROTEIN TYROSINE PHOSPHATASES, PROTEINS WITH SRC-MONOLOGY 2-DOMAINS; ANTICARCINOGENIC,-TUMOR AND DIABETIC AGENTS; PURIFICATION OF PROTEINS AND GLYCOPROTEINS; MEDICAL DIAGNOSIS NOVO NORDISK A/S (DK) 1999-09-28 — — US disclosed
WO-1997040017-A2 MODULATORS OF MOLECULES WITH PHOSPHOTYROSINE RECOGNITION UNITS NOVO NORDISK A/S (DK) 1997-10-30 — — WO disclosed
Send feedback